Catecholamine metabolism in affective disorders. I. Normetanephrine and VMA excretion in depressed patients treated with imipramine

scientific article published on 01 December 1965

Catecholamine metabolism in affective disorders. I. Normetanephrine and VMA excretion in depressed patients treated with imipramine is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0022-3956(65)90003-8
P698PubMed publication ID5866611

P2093author name stringJ J Schildkraut
E K Gordon
J Durell
P433issue4
P304page(s)213-228
P577publication date1965-12-01
P1433published inJournal of Psychiatric ResearchQ6295810
P1476titleCatecholamine metabolism in affective disorders. I. Normetanephrine and VMA excretion in depressed patients treated with imipramine
P478volume3

Reverse relations

cites work (P2860)
Q47640228A brief history of antidepressant drug development: from tricyclics to beyond ketamine
Q39964156A dualistic approach to some biochemical problems in endogenous depressions
Q41680522Antidepressant-Like and Antioxidant Effects of Plinia trunciflora in Mice.
Q40044181Biogenic Amines and Emotion
Q69517342Biogenic amines and their metabolites in body fluids of normal, psychiatric and neurological subjects
Q72368759Catechol amines and their metabolites in various states of ‘arousal’
Q70506826Catecholamine metabolism in affective disorders —IV. Preliminary studies of norepinephrine metabolism in depressed patients treated with amitriptyline
Q36540629Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories
Q43838094Cognitive and biochemical processes in depressed adult outpatients: a test of the circular process model
Q40038063Cyclic AMP in the CSF of Patients with Schizophrenia
Q41024140Decrease in brain NE turnover after chronic DMI treatment; no effect with iprindole
Q71668291Disturbance of tyrosine and tryptophane metabolism in depression
Q47123548Dopamine System Dysregulation in Major Depressive Disorders.
Q34502872Effects of a false neurotransmitter, p-hydroxynorephedrine, on the function of adrenergic neurons in hypertensive patients
Q48974440Effects of tricyclic antidepressants on the uptake and metabolism of intracisternally administered norepinephrine-H3 in rat brain
Q26828593Epigenetic effect of chronic stress on dopamine signaling and depression
Q43523869Hypertension and peptic ulcer
Q37198752Molecular epidemiology of major depressive disorder
Q37344751Neuropsychiatric disorders related to interferon and interleukins treatment
Q37823751Neurotransmitter Mechanisms during Mental Illness Induced by Alterations in Thyroid Function
Q53957522Noradrenergic activity during the transition from depression to mania.
Q95643364Novel Targets for Fast Antidepressant Responses: Possible Role of Endogenous Neuromodulators
Q61456993Plasma renin activity in primary and secondary depression
Q48431061Potentiating effect of lithium chloride on aggressive behaviour induced in mice by nialamide plus L-DOPA and by clonidine
Q70506833Psychobiological and pharmacological studies of manic-depressive illness
Q39973602Recent Contributions to Psychoendocrinology Part II
Q33945106Research and treatment approaches to depression
Q48465397Role of biogenic amines in certain pathological conditions
Q39514501Schizophrenia: instability in norepinephrine, serotonin, and gamma-aminobutyric acid systems.
Q72026328Schizophrenic Physiopathology
Q51230807The effects of lithium ion on H3 -norepinephrine metabolism in brain
Q51219079The effects of psychoactive drugs on norepinephrine-3H metabolism in brain
Q69544110The tyrosine-tryptophan-diagram in a longtime study with depressed patients
Q39992599Theories of Biological Etiology of Affective Disorders
Q70506830Thyroid-imipramine clinical and chemical interaction: Evidence for a receptor deficit in depression
Q72453816Thyrotropin releasing hormone: Neurochemical evidence for the potentiation of imipramine effects on the metabolism and uptake of brain catecholamines
Q72369366Tricyclic Antidepressants: Evidence for an Intraneuronal Site of Action
Q34048096Tryptophan, depression and steroidal contraception
Q69469954Urinary Catecholamine Metabolites during Behavioral Changes in a Patient with Manic-Depressive Cycles

Search more.